Cargando…

Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study

BACKGROUND: Direct oral anticoagulants (DOACs) are considered high-risk medications and used to prevent thromboembolic events and stroke. This study aimed to examine patients’ views and experiences of DOACs use and factors that can promote safety associated with DOACs. METHODS: In-depth interviews w...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Rowily, Abdulrhman, Baraka, Mohamed A., Abutaleb, Mohammed H., Alhayyan, Aliah M., Aloudah, Nouf, Jalal, Zahraa, Paudyal, Vibhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150668/
https://www.ncbi.nlm.nih.gov/pubmed/37127790
http://dx.doi.org/10.1186/s40545-023-00563-y
_version_ 1785035396287037440
author Al Rowily, Abdulrhman
Baraka, Mohamed A.
Abutaleb, Mohammed H.
Alhayyan, Aliah M.
Aloudah, Nouf
Jalal, Zahraa
Paudyal, Vibhu
author_facet Al Rowily, Abdulrhman
Baraka, Mohamed A.
Abutaleb, Mohammed H.
Alhayyan, Aliah M.
Aloudah, Nouf
Jalal, Zahraa
Paudyal, Vibhu
author_sort Al Rowily, Abdulrhman
collection PubMed
description BACKGROUND: Direct oral anticoagulants (DOACs) are considered high-risk medications and used to prevent thromboembolic events and stroke. This study aimed to examine patients’ views and experiences of DOACs use and factors that can promote safety associated with DOACs. METHODS: In-depth interviews were conducted with adult patients who had been prescribed DOACs, identified and invited by local collaborators in three different tertiary care hospitals in Saudi Arabia. A topic guide developed based on was used to inform the interview. Data were analysed thematically. RESULTS: Data saturation was achieved by the ninth participants. Three major themes were identified: (1) factors affecting DOAC's safety from the patients view; (2) barriers to adherence to DOACs and (3) strategies to promote the safety of DOACs. Lack of knowledge of DOACs, using inappropriate sources of information, lack of communication with HCPs, difficulty in having access to DOACs and lack of monitoring were the main factors affecting the safe use of DOACs. Unavailability of the drugs and difficulty in timely getting to hospitals affected adherence. Patients acknowledged difficulties communicating with healthcare professionals, timely access to anticoagulation clinics and in obtaining their DOACs on time. CONCLUSIONS: There is a need to develop and evaluate theory-based interventions to promote patient knowledge, understanding and shared decision-making to optimise DOACs use and improve their safety.
format Online
Article
Text
id pubmed-10150668
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101506682023-05-02 Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study Al Rowily, Abdulrhman Baraka, Mohamed A. Abutaleb, Mohammed H. Alhayyan, Aliah M. Aloudah, Nouf Jalal, Zahraa Paudyal, Vibhu J Pharm Policy Pract Research BACKGROUND: Direct oral anticoagulants (DOACs) are considered high-risk medications and used to prevent thromboembolic events and stroke. This study aimed to examine patients’ views and experiences of DOACs use and factors that can promote safety associated with DOACs. METHODS: In-depth interviews were conducted with adult patients who had been prescribed DOACs, identified and invited by local collaborators in three different tertiary care hospitals in Saudi Arabia. A topic guide developed based on was used to inform the interview. Data were analysed thematically. RESULTS: Data saturation was achieved by the ninth participants. Three major themes were identified: (1) factors affecting DOAC's safety from the patients view; (2) barriers to adherence to DOACs and (3) strategies to promote the safety of DOACs. Lack of knowledge of DOACs, using inappropriate sources of information, lack of communication with HCPs, difficulty in having access to DOACs and lack of monitoring were the main factors affecting the safe use of DOACs. Unavailability of the drugs and difficulty in timely getting to hospitals affected adherence. Patients acknowledged difficulties communicating with healthcare professionals, timely access to anticoagulation clinics and in obtaining their DOACs on time. CONCLUSIONS: There is a need to develop and evaluate theory-based interventions to promote patient knowledge, understanding and shared decision-making to optimise DOACs use and improve their safety. BioMed Central 2023-05-01 /pmc/articles/PMC10150668/ /pubmed/37127790 http://dx.doi.org/10.1186/s40545-023-00563-y Text en © Crown 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Al Rowily, Abdulrhman
Baraka, Mohamed A.
Abutaleb, Mohammed H.
Alhayyan, Aliah M.
Aloudah, Nouf
Jalal, Zahraa
Paudyal, Vibhu
Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
title Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
title_full Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
title_fullStr Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
title_full_unstemmed Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
title_short Patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
title_sort patients’ views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150668/
https://www.ncbi.nlm.nih.gov/pubmed/37127790
http://dx.doi.org/10.1186/s40545-023-00563-y
work_keys_str_mv AT alrowilyabdulrhman patientsviewsandexperiencesontheuseandsafetyofdirectlyactingoralanticoagulantsaqualitativestudy
AT barakamohameda patientsviewsandexperiencesontheuseandsafetyofdirectlyactingoralanticoagulantsaqualitativestudy
AT abutalebmohammedh patientsviewsandexperiencesontheuseandsafetyofdirectlyactingoralanticoagulantsaqualitativestudy
AT alhayyanaliahm patientsviewsandexperiencesontheuseandsafetyofdirectlyactingoralanticoagulantsaqualitativestudy
AT aloudahnouf patientsviewsandexperiencesontheuseandsafetyofdirectlyactingoralanticoagulantsaqualitativestudy
AT jalalzahraa patientsviewsandexperiencesontheuseandsafetyofdirectlyactingoralanticoagulantsaqualitativestudy
AT paudyalvibhu patientsviewsandexperiencesontheuseandsafetyofdirectlyactingoralanticoagulantsaqualitativestudy